Page last updated: 2024-09-03

loe 908 and hematoxylin

loe 908 has been researched along with hematoxylin in 1 studies

Compound Research Comparison

Studies
(loe 908)
Trials
(loe 908)
Recent Studies (post-2010)
(loe 908)
Studies
(hematoxylin)
Trials
(hematoxylin)
Recent Studies (post-2010) (hematoxylin)
50052,22825918

Protein Interaction Comparison

ProteinTaxonomyloe 908 (IC50)hematoxylin (IC50)
Chain E, Fibrin beta chainHomo sapiens (human)9.328
Chain A, RNA-directed RNA polymerase NS5Dengue virus 2 16681-PDK5317.36
Mcl-1Homo sapiens (human)3.4393
MPI proteinHomo sapiens (human)26.374
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonasePlasmodium berghei20.0467
VifHuman immunodeficiency virus 10.46
TatHuman immunodeficiency virus 111.696
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)0.46
large T antigenBetapolyomavirus macacae4.66

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christensen, T; Diemer, NH; Ensinger, HA; Wienrich, M1

Other Studies

1 other study(ies) available for loe 908 and hematoxylin

ArticleYear
The broad-spectrum cation channel blocker pinokalant (LOE 908 MS) reduces brain infarct volume in rats: a temperature-controlled histological study.
    Basic & clinical pharmacology & toxicology, 2005, Volume: 96, Issue:4

    Topics: Acetamides; Animals; Astrocytes; Blood Pressure; Body Temperature; Brain Infarction; Disease Models, Animal; Hematoxylin; Immunohistochemistry; Infusions, Intravenous; Isoquinolines; Male; Neuroglia; Rats; Rats, Wistar; Survival

2005